Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 6, 2001, Pages 1023-1028

  Ostos, Maria A ^a   Conconi, Mariangela ^a   Vergnes, Laurent ^a   Baroukh, Nadine ^a   Ribalta, Josep ^a   Girona, Josefa ^a   Caillaud, Jean Michel ^a   Ochoa, Alberto ^a   Zakin, Mario M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Antioxidants; Apolipoprotein A IV; Atherosclerosis; Transgenic mice

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCLONAL ANTIBODY; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0035715730     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.6.1023     Document Type: Article

References (33)

1. Role of oxidized low density lipoprotein in atherogenesis
2. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
3. The antioxidant butylated hydroxytoluene protects against atherosclerosis
4. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum
5. Apolipoprotein A-IV: A protein occurring in human mesenteric lymph chylomicrons and free in plasma: Isolation and quantification
6. Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content
7. Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph
8. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV
9. Human apoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum
10. Activation of lecithin: Cholesterol acyltransferase by human apolipoprotein A-IV
11. Role of apolipoprotein A IV in the interconversion of HDL subclasses
12. Lipoprotein apoC-II activation of lipoprotein lipase: Modulation by apolipoprotein A-IV
13. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV
14. Apolipoprotein AIV: A potent endogenous inhibitor of lipid oxidation
15. Regulation of the human apolipoprotein AIV gene expression in transgenic mice
16. Quantitative assessment of atherosclerotic lesions in mice
17. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles
18. Enhanced macrophage uptake of low density lipoprotein after self-aggregation
19. Carbonyl assays for determination of oxidatively modified proteins
20. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes
21. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
22. Increased ferritin gene expression in atherosclerotic lesions
23. Continuous monitoring of in vitro oxidation of human low density lipoprotein
24. Phagocytosis of lipaseaggregated low density lipoprotein promotes macrophage foam cell formation: Sequential morphological and biochemical events
25. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation
26. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice
27. Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated
28. Distribution patterns of apolipoproteins A1, A2, and B in the wall of atherosclerotic vessels
29. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants
30. Carbonic anhydrase III: Oxidative modification in vivo and loss of phosphatase activity during aging
31. Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis
32. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis
33. Clearance of cationized LDL cholesterol from a muscle depot is not enhanced in human apolipoprotein A-IV transgenic mice